FDAnews Drug Daily Bulletin

GENENTECH ACQUIRES THE ORIGENE TRUECLONECOLLECTION

March 29, 2006
A A

OriGene Technologies Inc. announced that Genentech has purchased their TrueClone Collection of full-length human cDNAs suitable for transfection and direct in vitro expression. Although there are many different efforts to collect every human full-length cDNA clones, OriGene's Trueclone Collection is the most comprehensive to date. OriGene cDNA clones are expression-ready, authentic full-length cDNA plasmids for use in target and lead identification and validation.
Finanzen.net